Steven Cohen’s Vanda Pharmaceuticals VNDA Stock Holding History

Steven Cohen’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	311,362 +149,766	+93%	+$978K	﹤0.01%	2419
2026 Q1	$1.12M	Buy	161,596 +100,130	+163%	+$772K	﹤0.01%	2700
2025 Q4	$542K	Buy	+61,466	New	+$338K	﹤0.01%	3195
2023 Q4	–	Sell	-57,490	Closed	-$248K	–	2877
2023 Q3	$248K	Buy	+57,490	New	+$319K	﹤0.01%	1710
2021 Q1	–	Sell	-170,000	Closed	-$2.23M	–	1192
2020 Q4	$2.23M	Buy	+170,000	New	+$2.05M	0.01%	713
2019 Q4	–	Sell	-223,375	Closed	-$2.97M	–	1271
2019 Q3	$2.97M	Buy	+223,375	New	+$3.11M	0.02%	538
2018 Q1	–	Sell	-125,000	Closed	-$1.9M	–	1142
2017 Q4	$1.9M	Buy	125,000 +25,000	+25%	+$371K	0.01%	746
2017 Q3	$1.79M	Sell	100,000 -1,842,400	-95%	-$30.8M	0.01%	694
2017 Q2	$31.7M	Sell	1,942,400 -542,100	-22%	-$7.81M	0.18%	152
2017 Q1	$34.8M	Buy	2,484,500 +2,333,400	+1,544%	+$33.3M	0.19%	138
2016 Q4	$2.41M	Sell	151,100 -391,600	-72%	-$6.29M	0.02%	540
2016 Q3	$9.03M	Buy	+542,700	New	+$7.31M	0.06%	299
2015 Q4	–	Sell	-1,900	Closed	-$21K	–	862
2015 Q3	$21K	Sell	1,900 -94,600	-98%	-$1.16M	﹤0.01%	727
2015 Q2	$1.23M	Buy	+96,500	New	+$1.04M	0.01%	601

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's VNDA Position: Q2 2026 in Review

Steven Cohen increased its Vanda Pharmaceuticals (VNDA) stake by 93% in Q2 2026, buying an estimated $978K and bringing the position to 311,362 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2419.

Steven Cohen first reported a position in VNDA in Q2 2015 and has held it in 14 quarters since. The position peaked at $34.8M in Q1 2017. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Steven Cohen held 311,362 shares of Vanda Pharmaceuticals worth $1.91M as of Q2 2026.
Steven Cohen bought 149,766 Vanda Pharmaceuticals shares in Q2 2026, an estimated $978K.
Vanda Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2419 holding.
Steven Cohen first reported a position in Vanda Pharmaceuticals in Q2 2015 and has held it in 14 quarters since.
Steven Cohen's Vanda Pharmaceuticals position peaked at $34.8M in Q1 2017.
171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.